Pfizer Wins Dismissal of Fraud Claims

Skadden represented Pfizer Inc. in its successful motion to dismiss RICO claims brought by Health Care Service Corporation alleging Pfizer improperly promoted off-label use for the drug Bextra. On August 2, Judge Charles Breyer of the U. S. District Court for the Northern District of California dismissed HCSC's claims with prejudice.